OneTest™ Premium for Pharmacies
OneTest™ Premium is a multi-cancer early detection test that can detect risk of cancer for many of the most commonly diagnosed cancers at early, more treatable stages. OneTest™ Capillary Panel can use a small blood sample that can be given at a participating pharmacy near you.
What’s Included:
- OneTest™ Premium test
- Medical authorization
- Capillary blood collection at pharmacy
- Specimen same-day delivery to lab via medical courier
What is OneTest™?
A multi-cancer early detection blood test for many of the most commonly diagnosed cancers including lung, liver, pancreas, and other cancers that are not widely screened for.
OneTest™ is a test in the category known as “MCED”‘s, multi-cancer early detection tests. OneTest™ analyzes cancer biomarkers and proprietary algorithms to calculate your risk of cancer. In the US, insurance covered cancer screening is normally limited to colon, breast and cervical cancer for women, and prostate cancer for men. Now OneTest™ offers broad cancer screening for multiple types of cancers, including lung, liver, pancreatic, ovarian, prostate, kidney and others.
We measure tumor antigens (not genes) which can help detect cancer now, not in the future
Many popular DNA testing companies today offer not only ancestry analysis, but also tests for inherited genetic abnormalities that pre-dispose the consumer to various diseases. Such tests have very limited value for early cancer detection since recent studies have confirmed that fewer than 5% of the genetic mutations that cause cancer are inherited. Instead, most cancer-causing mutations result from random DNA copying errors over time.
Our algorithms provide better accuracy than tumor markers alone.
We use machine learning to compare biomarker levels and other characteristics such as age and gender with a vast database of 28,000 subjects tested over 12 years. This approach has been demonstrated to help detect nearly twice as many cancers as biomarker testing alone. (See Accuracy, Reliability & Scientific Support for more details.)
OneTest™ is powered and validated by real-world data from asymptomatic individuals.
Most biomarker-based cancer tests are developed and validated using stored laboratory blood samples from cancer patients. The purported accuracy of these tests usually drops considerably when they are later used in a real-world screening setting (i.e. Individuals without signs or symptoms of cancer).
Silent Progression vs. Early Insight: The OneTest™ Advantage
Cancer doesn’t announce itself. By the time symptoms appear, critical months of treatment opportunity have been lost forever.
THE TRADITIONAL PATH
Early Detection Advantage
Why Customers Chose OneTest™
“As someone in healthcare, I appreciate the scientific approach. The at-home testing made it incredibly convenient.”
“OneTest detected elevated markers early, leading to a Stage 1 diagnosis. Early detection made all the difference.”
“I do the test annually for peace of mind. The process is simple, and the detailed reports help me stay proactive about my health.”
“OneTest detected elevated markers early, leading to a Stage 1 diagnosis. Early detection made all the difference.”
Frequently Asked Questions
Is OneTest a replacement for regular cancer screenings?
OneTest is designed to complement, not replace, standard cancer screenings like mammograms and colonoscopies. It provides an additional layer of protection by detecting biomarkers that may indicate cancer before symptoms appear.
How accurate is the test?
OneTest is designed to complement, not replace, standard cancer screenings like mammograms and colonoscopies. It provides an additional layer of protection by detecting biomarkers that may indicate cancer before symptoms appear.
Is the at-home collection difficult?
OneTest is designed to complement, not replace, standard cancer screenings like mammograms and colonoscopies. It provides an additional layer of protection by detecting biomarkers that may indicate cancer before symptoms appear.
What happens if my test shows elevated risk?
OneTest is designed to complement, not replace, standard cancer screenings like mammograms and colonoscopies. It provides an additional layer of protection by detecting biomarkers that may indicate cancer before symptoms appear.
Early cancer detection through advanced biomarker testing and Al analysis.
© 2025 OneTest™. All rights reserved. OneTest is not intended to diagnose, treat, cure or prevent any disease.